封面
市場調查報告書
商品編碼
1828163

2025年全球腎臟去神經支配設備市場報告

Renal Denervation Devices Global Market Report 2025

出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來,腎臟去神經支配器材市場快速擴張,市場規模從2024年的5.5億美元成長至2025年的7.4億美元,複合年成長率達33.1%。預測期內的成長歸因於高血壓病例數量的增加、臨床研究的開展、心血管疾病的增加、FDA的首批核准和監管發展,以及腎臟去神經支配系統的市場發展。

預計未來幾年腎臟去神經支配器材市場規模將呈指數級成長,到2029年將達到22.7億美元,複合年成長率為32.5%。預測期內的成長可歸因於以病人為中心的理念、醫療基礎設施的建設、認知度和接受度的提升、對微創治療的重視以及新型器械的上市。預測期內的主要趨勢包括人工智慧 (AI) 與機器學習的融合、監管格局的變化、向微創治療的轉變、對臨床證據的日益重視、遠端監控以及遠端醫療的整合。

腎臟去神經支配裝置是一種微創醫療解決方案,旨在治療對常規干預措施無效的頑固性高血壓。這類裝置需將導管插入腎動脈,並利用射頻能源消融血管壁內的交感神經。這一過程可以增強腎臟的血流。

腎臟去神經支配器材市場的主要產品包括Simplicity腎臟去神經支配系統、EnligHTN、Vessix腎臟去神經支配系統、Iberis腎臟交感神經去神經支配系統和Paradise腎臟去神經支配系統。例如,Simplicity腎臟去神經支配系統利用導管和發生器將射頻能源輸送至腎神經。這些器械採用多種技術,包括射頻消融術、基於超音波能量的腎臟去神經支配(RDN)、近距離放射治療和化學消融。目標終端使用者包括醫院、心血管研究機構和其他醫療機構。

2025年,美國關稅的大幅上調及其引發的貿易摩擦將對醫療設備產業產生重大影響,尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品的影響。由於醫院和診所抵制價格上漲,製造商面臨利潤壓力。監管挑戰使情況更加複雜,因為由於關稅而更換供應商通常需要醫療設備重新認證,導致市場進入延遲。為此,企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分,該系列提供腎去神經裝置光學元件市場統計數據,包括全球市場規模、區域佔有率、腎去神經裝置光學元件市場佔有率的競爭對手、詳細的腎去神經裝置光學元件細分市場、市場趨勢和商機,以及在腎去神經裝置光學元件行業取得成功所需的數據。本腎去神經裝置光學元件市場研究報告對該行業的現狀和未來趨勢進行了詳細分析,為您提供所需的一切觀點。

未來五年的預測成長率為32.5%,較我們先前對該市場的預測略有下降0.1%。下降主要源自於美國與其他國家之間關稅的影響。這將對美國產生直接影響,因為美國主要從荷蘭和愛爾蘭進口的射頻消融術導管和神經標測電極的關稅將提高,這可能會增加高血壓治療的成本。此外,由於互惠關稅以及貿易緊張局勢和限制加劇對全球經濟和貿易的負面影響,這種影響也將更加廣泛。

預計未來幾年,高血壓盛行率的上升將推動腎去神經支配器械市場的擴張。高血壓,俗稱血壓升高,是指血液對血管壁的壓力持續升高而導致的。腎去神經支配術是一種基於導管的治療方法,已成為難治性高血壓患者一種相當前景的治療方法。這種微創的、臨床實驗的治療方法旨在治療對標準藥物治療無效的高血壓。例如,美國政府機構疾病管制與預防中心於2024年5月報告稱,高血壓在2022年導致或直接導致了美國685,875人死亡。因此,預計高血壓盛行率的上升將推動腎去神經支配器械市場的成長。

預計腎臟去神經支配器材市場的成長將受到醫療保健支出成長的推動。醫療保健支出包括與提供醫療保健服務相關的所有費用,例如計劃生育援助、營養計劃和緊急醫療援助。不斷成長的醫療保健支出透過為患者和醫療保健系統提供資金支持,在促進腎臟去神經支配器械的普及方面發揮關鍵作用。例如,2023 年 6 月,美國醫療保險和醫療補助服務中心報告稱,到 2021 年,美國的醫療保健支出將成長 2.7%,達到 4.3 兆美元,即人均 12,914 美元,佔國內生產總值的 18.3%。醫療保健支出的這種上升趨勢進一步支撐了腎臟去神經支配器材市場的成長軌跡。

腎臟去神經支配設備市場的主要企業正專注於開發超音波腎臟去神經支配 (uRDN),以改善治療結果、最大限度地減少手術併發症,並提供傳統腎臟去神經支配方法的非侵入性替代方案。 uRDN 透過促進精確、非侵入性的能量輸送到腎臟神經來增強腎臟去神經支配設備,有效降低血壓同時保護周圍組織,從而提高患者在手術過程中的安全性和舒適度。例如,2023 年 11 月,美國醫療技術公司 Recor Medical Inc. 推出了 Paradise uRDN 系統,這是一款創新的超音波腎臟去神經支配設備,用於治療無法透過標準生活方式改變和藥物達到血壓目標的高血壓患者。該系統結合水冷技術,在手術過程中保護腎動脈,為管理難治性高血壓提供了一種新的非藥物方法,並擴大了患者的治療選擇,標誌著腎臟去神經支配設備市場的重大進步。

腎臟去神經支配器材市場的公司越來越重視引入微創治療方案,以增強其競爭地位。 2023年11月,美國醫療設備製造商Recor Medical在美國推出了Paradise超音波腎臟去神經支配療法。這是美國首個獲得FDA核准的腎臟去神經支配療法,利用超音波技術去除腎動脈周圍的交感神經,從而緩解高血壓引起的過度興奮。 Paradise系統在臨床試驗中顯示出顯著的降血壓效果,標誌著高血壓管理領域的重要進展。

2022年4月,英國綜合受託研究機構Clinical Accelerator與Verve Medical合作,針對一款專為難治性高血壓患者設計的創新醫療設備進行人體初步可行性研究。 Verve Medical是一家美國醫療設備製造商,在開發突破性解決方案以應對高血壓相關挑戰方面處於領先地位,進一步彰顯了該行業對持續創新的承諾。

腎臟去神經支配設備市場的主要企業包括美敦力公司 (Medtronic PLC)、ReCor Medical Inc.、波士頓科學公司 (Boston Scientific Corporation)、雅培實驗室 (Abbott Laboratories)、Cordis 公司、Terumo 公司、Kona Medical Inc.、St. Jude Medical LLC、強生公司 (Johnson & Medion InccatorS. Inc.、Cardiosonic Ltd.、Renal Dynamics Ltd.、Vesalio LLC、Atricure Inc.、Biosense Webster Inc.、Biotronik SE & Co. KG、Cook Medical LLC、Hansen Medical Inc.、Merit Medical Systems Inc.、AngioDynamics Inc.、Covidien Ltd.、Volcano 公司、Edwards Inc.、AngioDynamics Inc.、Covidien Ltd.、Volcano 公司、Edwards商人Ltd.、Oscor Inc. 和 Balton Sp. z oo。

2024年,歐洲是腎臟去神經支配器材市場最大的地區。根據全球腎臟去神經支配器材市場報告,預計亞太地區將成為預測期內成長最快的地區。腎臟去神經支配器材市場報告涵蓋亞太地區、西歐、中歐和東歐、北美、南美以及中東和非洲。

腎臟去神經支配裝置市場報告涉及的國家有澳洲、巴西、中國、法國、德國、印度、印尼、日本、俄羅斯、韓國、英國、美國、加拿大、義大利和西班牙。

腎臟去神經支配器材市場涵蓋單電極、多電極、灌注導管等產品的銷售。該市場的價值指的是“出廠價”,即產品製造商或生產商銷售給其他營業單位(包括下游製造商、批發商、經銷商和零售商)或直接銷售給最終客戶的價值。該市場的產品價值還包括產品製造商銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場:宏觀經濟情景,包括利率、通膨、地緣政治、貿易戰和關稅,以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球腎臟去神經支配裝置:PESTEL 分析(政治、社會、技術、環境、法律因素、促進因素和限制因素)
  • 最終用途產業分析
  • 全球腎臟去神經支配設備市場:成長率分析
  • 全球腎臟去神經支配裝置市場表現:規模與成長,2019-2024
  • 全球腎臟去神經支配裝置市場預測:規模與成長,2024-2029,2034
  • 全球腎臟去神經支配裝置:總目標市場(TAM)

第6章 市場細分

  • 全球腎臟去神經支配設備市場:依產品、績效及預測,2019-2024 年、2024-2029 年、2034 年
  • 簡易腎臟去神經支配系統
  • EnligHTN
  • Vessix 腎臟去神經支配系統
  • Iberis 腎交感神經去神經支配系統
  • 天堂腎臟去神經系統
  • 其他產品
  • 全球腎臟去神經支配設備市場(按技術、性能和預測),2019-2024 年、2024-2029 年、2034 年
  • 射頻消融術
  • 基於超音波能量的RDN
  • 近距離放射治療
  • 科學消融
  • 其他
  • 全球腎臟去神經支配設備市場(依最終用戶、績效及預測),2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 心血管研究所
  • 其他
  • 全球腎臟去神經支配設備市場:簡易腎臟去神經支配系統細分市場,按類型、表現和預測,2019-2024 年、2024-2029 年、2034 年
  • 導管系統
  • 配件
  • 全球腎臟去神經支配設備市場:EnligHTN 細分市場、類型、績效及預測(2019-2024 年、2024-2029 年、2034 年)
  • 導管系統
  • 發電機
  • 配件
  • 全球腎臟去神經支配設備市場:Vessix 腎臟去神經支配系統細分市場、類型、表現及預測(2019-2024 年、2024-2029 年、2034 年)
  • 球囊導管
  • 發電機
  • 配件
  • 全球腎臟去神經支配設備市場:Iberis 腎臟交感神經去神經支配系統細分市場、按類型、表現和預測,2019-2024 年、2024-2029 年、2034 年
  • 導管系統
  • 配件
  • 全球腎臟去神經支配設備市場:天堂腎臟去神經支配系統細分市場,按類型、表現和預測,2019-2024 年、2024-2029 年、2034 年
  • 導管系統
  • 配件
  • 全球腎臟去神經支配設備市場:其他細分市場、按類型、績效及預測,2019-2024 年、2024-2029 年、2034 年
  • 新興技術
  • 替代設備

第7章 區域和國家分析

  • 全球腎臟去神經支配設備市場:依地區、績效及預測,2019-2024 年、2024-2029 年、2034 年
  • 全球腎臟去神經支配設備市場:國家、績效及預測(2019-2024、2024-2029、2034)

第8章 亞太市場

第9章:中國市場

第10章 印度市場

第11章 日本市場

第12章:澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章:德國市場

第18章:法國市場

第19章:義大利市場

第20章:西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章:加拿大市場

第26章 南美洲市場

第27章:巴西市場

第28章 中東市場

第29章:非洲市場

第30章:競爭格局與公司概況

  • 腎臟去神經支配裝置市場:競爭格局
  • 腎臟去神經支配設備市場:公司簡介
    • Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
    • ReCor Medical Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Cordis Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章:其他領先和創新企業

  • Terumo Corporation
  • Kona Medical Inc.
  • St. Jude Medical LLC
  • Johnson & Johnson
  • Mercator MedSystems Inc.
  • Symple Surgical Inc.
  • Ablative Solutions Inc.
  • Cardiosonic Ltd.
  • Renal Dynamics Ltd.
  • Vesalio LLC
  • Atricure Inc.
  • Biosense Webster Inc.
  • Biotronik SE & Co. KG
  • Cook Medical LLC
  • Hansen Medical Inc.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章:高潛力市場國家、細分市場與策略

  • 2029年腎臟去神經支配設備市場:提供新機會的國家
  • 2029年腎臟去神經支配設備市場:細分市場帶來新機會
  • 腎臟去神經支配設備市場 2029 年:成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r24451u

Renal denervation devices represent minimally invasive medical solutions designed for the treatment of resistant hypertension cases unresponsive to conventional interventions. These devices involve the insertion of a catheter into the renal arteries, employing radiofrequency energy to ablate sympathetic nerves within the vessel walls. This process enhances blood flow to the kidneys.

Key products in the renal denervation devices market include the Simplicity Renal Denervation System, EnligHTN, Vessix Renal Denervation System, Iberis Renal Sympathetic Denervation System, Paradise Renal Denervation System, and others. The Simplicity Renal Denervation System, for instance, utilizes a catheter and generator to deliver radiofrequency energy to the renal nerves. Various technologies, such as radiofrequency ablation, ultrasound energy-based RDN, brachytherapy, chemical ablation, and others, are employed by these devices. Target end-users include hospitals, cardiovascular research centers, and other medical facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The renal denervation devices market research report is one of a series of new reports from The Business Research Company that provides renal denervation devices optical components market statistics, including renal denervation devices optical components industry global market size, regional shares, competitors with a renal denervation devices optical components market share, detailed renal denervation devices optical components market segments, market trends and opportunities, and any further data you may need to thrive in the renal denervation devices optical components industry. This renal denervation devices optical components market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The renal denervation devices market size has grown exponentially in recent years. It will grow from $0.55 billion in 2024 to $0.74 billion in 2025 at a compound annual growth rate (CAGR) of 33.1%. The growth in the historic period can be attributed to increased hypertension cases, clinical research and studies, increased in cardiovascular diseases, initial FDA approval and regulatory developments, market entry of renal denervation systems.

The renal denervation devices market size is expected to see exponential growth in the next few years. It will grow to $2.27 billion in 2029 at a compound annual growth rate (CAGR) of 32.5%. The growth in the forecast period can be attributed to patient-centric approach, healthcare infrastructure development, growing awareness and acceptance, focus on minimally invasive therapies, market entry of new devices. Major trends in the forecast period include integration of artificial intelligence (ai) and machine learning, regulatory landscape changes, shift towards minimally invasive procedures, emphasis on clinical evidence, remote monitoring and telehealth integration.

The forecast of 32.5% growth over the next five years indicates a slight reduction of 0.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through increased tariffs on radiofrequency ablation catheters and nerve mapping electrodes, mainly imported from the Netherlands and Ireland, raising costs for hypertension treatment.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising prevalence of hypertension is projected to stimulate the expansion of the renal denervation devices market in the coming years. Hypertension, commonly referred to as high blood pressure, occurs when the force of blood against the walls of the blood vessels remains consistently elevated. Renal denervation is a catheter-based procedure that has emerged as a promising treatment option for patients with resistant hypertension. This minimally invasive, investigational technique is designed to address hypertension that has not responded to standard medications. For instance, in May 2024, the Centers for Disease Control and Prevention, a US government agency, reported that high blood pressure was a contributing factor in or directly caused 685,875 deaths in the United States in 2022. Thus, the increasing prevalence of hypertension is expected to drive growth in the renal denervation devices market.

The growth of the renal denervation devices market is expected to be propelled by the rise in healthcare expenditures. Healthcare expenditures encompass all costs associated with providing health services, including support for family planning, nutrition programs, and emergency health assistance. Increased healthcare spending plays a pivotal role in fostering the adoption of renal denervation devices by providing financial support for both patients and healthcare systems. As an example, in June 2023, the Centers for Medicare & Medicaid Services reported a 2.7% increase in healthcare expenditure in the United States, totaling $4.3 trillion or $12,914 per person in 2021, constituting 18.3% of the nation's gross domestic product. This upward trend in healthcare spending further supports the growth trajectory of the renal denervation devices market.

Leading companies in the renal denervation devices market are concentrating on the development of ultrasound renal denervation (uRDN) to improve treatment effectiveness, minimize procedural complications, and offer a non-invasive alternative to conventional renal denervation methods. uRDN enhances renal denervation devices by facilitating precise, non-invasive energy delivery to the renal nerves, which effectively reduces blood pressure while safeguarding surrounding tissues, thereby increasing patient safety and comfort during the procedure. For example, in November 2023, Recor Medical Inc., a US-based medical technology firm, introduced the Paradise uRDN system, an innovative ultrasound renal denervation device aimed at treating hypertension in patients who have not reached blood pressure targets through standard lifestyle modifications and medications. This system incorporates hydrocooling technology to protect the renal artery during the procedure, marking a significant advancement in the renal denervation devices market by providing a novel, non-pharmacologic method for managing resistant hypertension and broadening treatment options for patients.

Companies operating in the renal denervation devices market are increasingly emphasizing the introduction of minimally invasive options to strengthen their competitive position. In November 2023, Recor Medical, another US-based medical device company, launched the Paradise Ultrasound Renal Denervation Therapy in the United States. This marked the first FDA-approved renal denervation therapy in the country, utilizing ultrasound technology to denervate sympathetic nerves surrounding the renal arteries and mitigating overactivity that can contribute to hypertension. The Paradise System has exhibited significant blood pressure reductions in clinical trials, representing a crucial advancement in hypertension management.

In April 2022, Clinical Accelerator, a UK-based full-service contract research organization, collaborated with Verve Medical to conduct a preliminary human feasibility study on an innovative medical device designed for individuals facing treatment-resistant hypertension. Verve Medical Inc., a US-based medical equipment manufacturer, is at the forefront of developing groundbreaking solutions to address the challenges associated with hypertension, further underscoring the industry's commitment to continuous innovation.

Major companies operating in the renal denervation devices market include Medtronic PLC, ReCor Medical Inc., Boston Scientific Corporation, Abbott Laboratories, Cordis Corporation, Terumo Corporation, Kona Medical Inc., St. Jude Medical LLC, Johnson & Johnson, Mercator MedSystems Inc., Symple Surgical Inc., Ablative Solutions Inc., Cardiosonic Ltd., Renal Dynamics Ltd., Vesalio LLC, Atricure Inc., Biosense Webster Inc., Biotronik SE & Co. KG, Cook Medical LLC, Hansen Medical Inc., Merit Medical Systems Inc., AngioDynamics Inc., Covidien Ltd., Volcano Corporation, Edwards Lifesciences Corporation, InnoVein Inc., Teleflex Incorporated, Medinol Ltd., Oscor Inc., Balton Sp. z o.o.

Europe was the largest region in the renal denervation devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global renal denervation devices market report during the forecast period. The regions covered in the renal denervation devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the renal denervation devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The renal denervation devices market consists of sales of products including a single electrode, multi-electrode, irrigated catheter, and others. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Renal Denervation Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on renal denervation devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for renal denervation devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The renal denervation devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Simplicity Renal Denervation System; EnligHTN; Vessix Renal Denervation System; Iberis Renal Sympathetic Denervation System; Paradise Renal Denervation System; Other Products
  • 2) By Technology: Radio Frequency Ablation; Ultrasound Energy-Based RDN; Brachytherapy; Chemical Ablation; Other Technologies
  • 3) By End-Users: Hospitals; Cardiovascular research centre; Other End-Users
  • Subsegments:
  • 1) By Simplicity Renal Denervation System: Catheter System; Accessories
  • 2) By EnligHTN: Catheter System; Generator; Accessories
  • 3) By Vessix Renal Denervation System: Balloon Catheter; Generator; Accessories
  • 4) By Iberis Renal Sympathetic Denervation System: Catheter System; Accessories
  • 5) By Paradise Renal Denervation System: Catheter System; Accessories
  • 6) By Other Products: Emerging Technologies; Alternative Devices
  • Companies Mentioned: Medtronic PLC; ReCor Medical Inc.; Boston Scientific Corporation; Abbott Laboratories; Cordis Corporation; Terumo Corporation; Kona Medical Inc.; St. Jude Medical LLC; Johnson & Johnson; Mercator MedSystems Inc.; Symple Surgical Inc.; Ablative Solutions Inc.; Cardiosonic Ltd.; Renal Dynamics Ltd.; Vesalio LLC; Atricure Inc.; Biosense Webster Inc.; Biotronik SE & Co. KG; Cook Medical LLC; Hansen Medical Inc.; Merit Medical Systems Inc.; AngioDynamics Inc.; Covidien Ltd.; Volcano Corporation; Edwards Lifesciences Corporation; InnoVein Inc.; Teleflex Incorporated; Medinol Ltd.; Oscor Inc.; Balton Sp. z o.o.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Renal Denervation Devices Market Characteristics

3. Renal Denervation Devices Market Trends And Strategies

4. Renal Denervation Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Renal Denervation Devices Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Renal Denervation Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Renal Denervation Devices Market Growth Rate Analysis
  • 5.4. Global Renal Denervation Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Renal Denervation Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Renal Denervation Devices Total Addressable Market (TAM)

6. Renal Denervation Devices Market Segmentation

  • 6.1. Global Renal Denervation Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Simplicity Renal Denervation System
  • EnligHTN
  • Vessix Renal Denervation System
  • Iberis Renal Sympathetic Denervation System
  • Paradise Renal Denervation System
  • Other Products
  • 6.2. Global Renal Denervation Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Radio Frequency Ablation
  • Ultrasound Energy-Based RDN
  • Brachytherapy
  • Chemical Ablation
  • Other Technologies
  • 6.3. Global Renal Denervation Devices Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Cardiovascular research centre
  • Other End-Users
  • 6.4. Global Renal Denervation Devices Market, Sub-Segmentation Of Simplicity Renal Denervation System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Catheter System
  • Accessories
  • 6.5. Global Renal Denervation Devices Market, Sub-Segmentation Of EnligHTN, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Catheter System
  • Generator
  • Accessories
  • 6.6. Global Renal Denervation Devices Market, Sub-Segmentation Of Vessix Renal Denervation System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Balloon Catheter
  • Generator
  • Accessories
  • 6.7. Global Renal Denervation Devices Market, Sub-Segmentation Of Iberis Renal Sympathetic Denervation System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Catheter System
  • Accessories
  • 6.8. Global Renal Denervation Devices Market, Sub-Segmentation Of Paradise Renal Denervation System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Catheter System
  • Accessories
  • 6.9. Global Renal Denervation Devices Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Emerging Technologies
  • Alternative Devices

7. Renal Denervation Devices Market Regional And Country Analysis

  • 7.1. Global Renal Denervation Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Renal Denervation Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Renal Denervation Devices Market

  • 8.1. Asia-Pacific Renal Denervation Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Renal Denervation Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Renal Denervation Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Renal Denervation Devices Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Renal Denervation Devices Market

  • 9.1. China Renal Denervation Devices Market Overview
  • 9.2. China Renal Denervation Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Renal Denervation Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Renal Denervation Devices Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Renal Denervation Devices Market

  • 10.1. India Renal Denervation Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Renal Denervation Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Renal Denervation Devices Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Renal Denervation Devices Market

  • 11.1. Japan Renal Denervation Devices Market Overview
  • 11.2. Japan Renal Denervation Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Renal Denervation Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Renal Denervation Devices Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Renal Denervation Devices Market

  • 12.1. Australia Renal Denervation Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Renal Denervation Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Renal Denervation Devices Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Renal Denervation Devices Market

  • 13.1. Indonesia Renal Denervation Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Renal Denervation Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Renal Denervation Devices Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Renal Denervation Devices Market

  • 14.1. South Korea Renal Denervation Devices Market Overview
  • 14.2. South Korea Renal Denervation Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Renal Denervation Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Renal Denervation Devices Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Renal Denervation Devices Market

  • 15.1. Western Europe Renal Denervation Devices Market Overview
  • 15.2. Western Europe Renal Denervation Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Renal Denervation Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Renal Denervation Devices Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Renal Denervation Devices Market

  • 16.1. UK Renal Denervation Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Renal Denervation Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Renal Denervation Devices Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Renal Denervation Devices Market

  • 17.1. Germany Renal Denervation Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Renal Denervation Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Renal Denervation Devices Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Renal Denervation Devices Market

  • 18.1. France Renal Denervation Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Renal Denervation Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Renal Denervation Devices Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Renal Denervation Devices Market

  • 19.1. Italy Renal Denervation Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Renal Denervation Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Renal Denervation Devices Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Renal Denervation Devices Market

  • 20.1. Spain Renal Denervation Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Renal Denervation Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Renal Denervation Devices Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Renal Denervation Devices Market

  • 21.1. Eastern Europe Renal Denervation Devices Market Overview
  • 21.2. Eastern Europe Renal Denervation Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Renal Denervation Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Renal Denervation Devices Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Renal Denervation Devices Market

  • 22.1. Russia Renal Denervation Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Renal Denervation Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Renal Denervation Devices Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Renal Denervation Devices Market

  • 23.1. North America Renal Denervation Devices Market Overview
  • 23.2. North America Renal Denervation Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Renal Denervation Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Renal Denervation Devices Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Renal Denervation Devices Market

  • 24.1. USA Renal Denervation Devices Market Overview
  • 24.2. USA Renal Denervation Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Renal Denervation Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Renal Denervation Devices Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Renal Denervation Devices Market

  • 25.1. Canada Renal Denervation Devices Market Overview
  • 25.2. Canada Renal Denervation Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Renal Denervation Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Renal Denervation Devices Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Renal Denervation Devices Market

  • 26.1. South America Renal Denervation Devices Market Overview
  • 26.2. South America Renal Denervation Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Renal Denervation Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Renal Denervation Devices Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Renal Denervation Devices Market

  • 27.1. Brazil Renal Denervation Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Renal Denervation Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Renal Denervation Devices Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Renal Denervation Devices Market

  • 28.1. Middle East Renal Denervation Devices Market Overview
  • 28.2. Middle East Renal Denervation Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Renal Denervation Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Renal Denervation Devices Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Renal Denervation Devices Market

  • 29.1. Africa Renal Denervation Devices Market Overview
  • 29.2. Africa Renal Denervation Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Renal Denervation Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Renal Denervation Devices Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Renal Denervation Devices Market Competitive Landscape And Company Profiles

  • 30.1. Renal Denervation Devices Market Competitive Landscape
  • 30.2. Renal Denervation Devices Market Company Profiles
    • 30.2.1. Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. ReCor Medical Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Cordis Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Renal Denervation Devices Market Other Major And Innovative Companies

  • 31.1. Terumo Corporation
  • 31.2. Kona Medical Inc.
  • 31.3. St. Jude Medical LLC
  • 31.4. Johnson & Johnson
  • 31.5. Mercator MedSystems Inc.
  • 31.6. Symple Surgical Inc.
  • 31.7. Ablative Solutions Inc.
  • 31.8. Cardiosonic Ltd.
  • 31.9. Renal Dynamics Ltd.
  • 31.10. Vesalio LLC
  • 31.11. Atricure Inc.
  • 31.12. Biosense Webster Inc.
  • 31.13. Biotronik SE & Co. KG
  • 31.14. Cook Medical LLC
  • 31.15. Hansen Medical Inc.

32. Global Renal Denervation Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Renal Denervation Devices Market

34. Recent Developments In The Renal Denervation Devices Market

35. Renal Denervation Devices Market High Potential Countries, Segments and Strategies

  • 35.1 Renal Denervation Devices Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Renal Denervation Devices Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Renal Denervation Devices Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer